ATYR — ATYR PHARMA INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ATYR PHARMA INC (ATYR)
ATYR PHARMA INC (ATYR) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $1M. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ATYR
How many top investors track ATYR
Only 2 tracked investors report this position.
ATYR Ownership Composition
How ATYR PHARMA INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ATYR
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.6MValue$1.3M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares203.4KValue$158.6K% Portfolio0.00%
Recent activity
- $1.3MMay 15, 2026
- New$158.6KMay 15, 2026
- New$605.3KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ATYR?
- 2 tracked institutional investors disclosed a position in ATYR (ATYR PHARMA INC) in their most recent 13F filing.
- Who is the largest institutional holder of ATYR?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ATYR, valued at $1M.
- Did institutional ownership of ATYR increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 fully exited ATYR.
- Where does this ATYR ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.